ReleaseWire Connect

In today's information age, medical device connectivity allows establishment of connection between various medical equipment and devices in a healthcare setting for information sharing. The global medical automation market attained market value of $ 43,200 million in 2013 and expected to have a sustained growth. Medical devices connectivity market is gaining significance as it allows better patient monitoring and information system, which is the key driver of the market. Additionally, the connected medical devices carry important information such as maintenance schedule along with device tracking system through real time location system (RTLS).

The global medical automation technologies market provides various automated services in health monitoring, prescriptions, therapeutics etc. The global medical technologies market revenue stood at $300 billion in 2011 and it is expected to grow at a CAGR of 7% by 2016. The medical automation technologies market is expected to have a significant market share as highly automated and sophisticated services are available in the market. Venture capitalists are investing in the market to boost the development of medical automation, which is a key driver for the market. For example, Google started a healthcare company, Calio, and is now developing smart contact lens for monitoring diabetes.

Testing for presence of toxic compounds is an important step during development of new products such as drugs, cosmetics, and food additives, which can save both time and developmental costs as well as reduce the probability of failure during later stages. In vitro toxicity testing is a procedure that helps examine the presence of these toxic compounds over an isolated part of the organism.

The global early toxicity testing market was $614 million in 2015 and is estimated to reach $1,012 million by 2022, registering a CAGR of 7.3% from 2016 to 2022. In early toxicity testing, different techniques such as in vivo and in vitro are used to evaluate the adverse effects of the product on human health. Toxicity tests at early stage of drug development help reduce the risk of later stage failures. As the awareness regarding the welfare of human health and environment has increased, the stringency of regulatory approvals has also increased. As toxicity studies help assess the safety issue of the product, the increased stringency of the government regulators will help increase the adoption rate of toxicity techniques among the different companies.

A Report Titled "Global Baby Hygiene Products Market Research Report" highlights status and outlook of geographical boundaries of the industry. It provides a detailed analysis of factors that are capable to drive or inhibit growth of the market.

Diabetes care market comprises of technologies, devices and therapeutics markets in relation to diabetes. As estimated by The World Diabetes Foundation, there would be 438 million people suffering from diabetes by 2030. Approximately 11.6% of the global healthcare expenditure is shared by diabetes care. In 2010, global expenditure on diabetes was $376 billion. Global diabetes management product market was valued $41 billion in 2012. Sedentary lifestyle and obesity are primary factors driving the diabetes care market. There has been a considerable rise in the number of diabetes cases globally over the last few years. Improper diet and sedentary lifestyle are the main risk-elevating factors. Currently, about 528.7 million people are suffering from obesity, which is a primary reason for development of diabetes in people.

"Global Early Education Machine Market Research Report 2017" report entails the qualitative and quantitative analysis of current and future market estimations. It also divulges details about the mode of research methodology used for the study. It includes data from primary as well as secondary resources. The report is a useful resource for industry players, new entrants in the marketplace, and investors as it helps them plan their business to gain fruitful and meaningful outcomes. It makes them aware of the production, capacity, revenue, supply, consumption, export, import, the challenges and risks associated with the industry, and much more. The report has a mention of the market drivers and opportunities. Key players are profiled in the report and their developments in recent years are mentioned, which helps in understanding the competitive outlook of the global Early Education Machine market.

A blood gas test measures the amount of oxygen and carbon dioxide in the blood. It is also used to determine the pH and acidic content of the blood. The test is commonly known as a blood gas analysis or arterial blood gas (ABG) test. Imbalances in the oxygen, carbon dioxide, and pH levels of your blood indicate the presence of certain medical conditions. These products are used in emergency departments for the diagnosis of various diseases including kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, a drug overdose, shock, asthma, and chronic obstructive pulmonary disorder (COPD).

Radiopharmaceuticals are pharmaceutical formulations comprising radioactive isotopes that are used in diagnosis and therapeutics. They are simple and small substances that contain a radioactive substance that is used in the treatment of cancer and cardiac & neurological disorders. The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only helps physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. Radiopharmaceuticals, also known as nuclear medicines, are used in applications such as lymphoma and bone metastasis. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures, while I-131, Ir-192, Y-90, I-125, Lu-177, and Ra-223 are used in therapeutics procedures.

Metabolomics is an emerging field of science that performs systematic quantification and classification of metabolites in a biological system by using sophisticated analytical technologies. The analytical techniques used include spectroscopy, chromatography, and multivariate analysis. The global metabolomics market accounted for $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023.